The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (P) in patients (Pts) with colorectal cancer (CRC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
 
Eyal Meiri
Employment - Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America (I); Cancer Treament Centers of America (I); Cancer Treament Centers of America (I); Cancer Treament Centers of America (I)
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen
 
Elizabeth Garrett-Mayer
Stock and Other Ownership Interests - Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Abbvie; Abbvie; Abbvie; Abbvie
Consulting or Advisory Role - Deciphera; Deciphera; Deciphera; Deciphera; Okava Pharmaceuticals; Okava Pharmaceuticals; Okava Pharmaceuticals; Okava Pharmaceuticals; Tactical Therapeutics; Tactical Therapeutics; Tactical Therapeutics; Tactical Therapeutics; TYME; TYME; TYME; TYME
 
Susan Halabi
Employment - ASCO; ASCO; ASCO; ASCO
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Ferring; Ferring; Ferring; Ferring
 
Pam K. Mangat
No Relationships to Disclose
 
Sagun Shrestha
No Relationships to Disclose
 
Eugene R. Ahn
Employment - Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America
Leadership - Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America; Cancer Treament Centers of America
 
Olufunlayo Osayameh
No Relationships to Disclose
 
Venu Perla
Patents, Royalties, Other Intellectual Property - Received patent royalties from the Purdue University, West Lafayette, IN, USA.; Received patent royalties from the Purdue University, West Lafayette, IN, USA.; Received patent royalties from the Purdue University, West Lafayette, IN, USA.; Received patent royalties from the Purdue University, West Lafayette, IN, USA.
 
Richard L. Schilsky
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems